Live from the NIH registry
Studies recruiting near Albuquerque right now
Top 25 of 344 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lovelace Medical Center - Saint Joseph Square — Albuquerque, New Mexico (1.5 mi)
· Sponsor: American Society of Clinical Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Renal Medicine Associates — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Sameek Roychowdhury
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
292 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Corcept Therapeutics
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Kura Oncology, Inc.
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
University of New Mexico Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Incyte Corporation
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
New Mexico VA Health Care System, Albuquerque, NM — Albuquerque, New Mexico (1.5 mi)
· Sponsor: VA Office of Research and Development
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Cancer, Cancer Risk
N/A
Observational 47,500 participants sought
University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Mexico Cancer Research Alliance
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Raymond G. Murphy VA — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Hemorrhagic Shock, Trauma Injury
Phase 3
Interventional 1,000 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Philip Spinella
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Convergence Insufficiency, Traumatic Brain Injury
N/A
Interventional 100 participants sought
New Mexico VA Health Care System — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Jersey Institute of Technology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Albuquerque, New Mexico (1.5 mi)
· Sponsor: AstraZeneca
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Jaeb Center for Health Research
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Yale University
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0381 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Bristol-Myers Squibb
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
New Mexico Heart — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Abiomed Inc.
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Hematologic Tests
N/A
Interventional 425 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Abbott Point of Care
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)